Currently, there are 429.00M common shares owned by the public and among those 384.40M shares have been available to trade.
The company’s stock has a 5-day price change of -2.91% and -10.87% over the past three months. TOST shares are trading 31.60% year to date (YTD), with the 12-month market performance up to 10.23% higher. It has a 12-month low price of $13.77 and touched a high of $27.90 over the same period. TOST has an average intraday trading volume of 7.13 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.13%, -3.45%, and 11.24% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Toast Inc (NYSE: TOST) shares accounts for 73.42% of the company’s 429.00M shares outstanding.
It has a market capitalization of $13.34B and a beta (3y monthly) value of 1.76. The earnings-per-share (ttm) stands at -$0.25. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.29% over the week and 4.73% over the month.
Earnings per share for the fiscal year are expected to increase by 431.52%, and 52.14% over the next financial year. EPS should shrink at an annualized rate of -14.83% over the next five years, compared to -2.90% over the past 5-year period.
Looking at the support for the TOST, a number of firms have released research notes about the stock. Mizuho stated their Outperform rating for the stock in a research note on July 18, 2024, with the firm’s price target at $21-$33. Wedbush coverage for the Toast Inc (TOST) stock in a research note released on May 24, 2024 offered a Outperform rating with a price target of $30. Robert W. Baird was of a view on May 21, 2024 that the stock is Neutral, while Keefe Bruyette gave the stock Mkt Perform rating on April 09, 2024, issuing a price target of $25. Exane BNP Paribas on their part issued Outperform rating on March 07, 2024.
